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ABSTRACT 
JESSICA ANN SORRENTINO: The effects of chronic and acute toxicological exposures on 
the expression of the tumor suppressor p16
INK4a
 
(Under the direction of Dr. Norman E Sharpless) 
  
 In mammals, expression of p16
INK4a
 is highly regulated.  Excess expression can lead 
to cellular senescence and aging, while impaired activation is associated with cancer.  The 
precise mechanism of p16
INK4a
 regulation in vivo is poorly understood.  In vitro systems have 
limited utility since proliferation in culture induces p16
INK4a
.  Both extrinsic (chemotherapy 
and ionizing radiation) and intrinsic (telomere shortening and improper DNA damage repair) 
stimuli can induce p16
INK4a
, but the kinetics of and cellular responses to these genomic 
insults have not been examined in vivo.  To address this question, we developed a murine 
strain with firefly luciferase ‘knocked-in’ to the endogenous p16INK4a locus and under control 
of the p16
INK4a
 promoter (p16
LUC
).   
 To determine the expression of p16
INK4a
 after chronic exposure, we exposed p16
LUC
 
mice to 50 ppm arsenic (As), 42% fat diet (HFD), 350 J/m
2
 Ultraviolet B light (UVB), or 
cigarette smoke (CS) for a minimum of 6 months.  Every other month, p16
LUC
 mice were 
imaged to measure luciferase induction.  At 30 weeks of exposure, mice exposed to CS 
displayed 2 times higher levels of whole body luciferase activity than ambient air (AA) 
controls.  Additionally, mice exposed to UVB exhibited 1.5 times higher levels of luciferase 
activity by 6 weeks of exposure that reached 8 times over control mice by 24 weeks.  In As 
exposed mice, there was a slight, but statistically significant induction of p16
INK4a
 by 24 
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weeks.  We observed no differences in p16
INK4a
 expression in mice on HFD compared to 
normal diet (ND, 4%) after 78 weeks.  We can deduce the direct DNA damaging agents, CS 
and UVB, are leading to an induction of p16
INK4a
 while in direct DNA-damaging agents (e.g. 
As) cause a slight induction of p16
INK4a
.  However, non-DNA damaging agents, such as 
HFD, show no changes in expression when compared to ND controls.  
 To determine the regulation of transient p16
INK4a
 expression, mice were exposed to a 
high dose of UVB light (2000 J/m
2
).  The mice were then imaged for luciferase induction at 
various time points over one month, allowing the burn to heal.  To manipulate the induction 
of p16
INK4a
 the mice were treated with pharmacological inhibitors, including dexamethasone 
(dex), clodrosome (clod), and compound A (cA).  Dex, a known immunosuppression, 
showed a decrease in p16
LUC
 expression, during the healing process along with clod, known 
to be toxic to macrophages, and cA, a p65 inhibitor.  This data suggests that inflammation at 
the site of the burn can lead to the induction of p16
INK4a
 through the recruitment of 
macrophages along the Nfκb pathway.  The data generated from these experiments will 
demonstrate how environmental exposures are associated with expression of p16
INK4a
, a 
mediator of tumor suppression and aging. 
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CHAPTER 1: INTRODUCTION 
 Aging is a complex process with contributions from both genetic and environmental 
factors.  There has been a great effort to determine how environmental agents are 
carcinogenic, but very few studies have been done to show how long term exposures can lead 
to aging (Goldsworthy et al., 1994; Jacobson-Kram et al., 2004).  Long term studies, 
independent of research goal, are extremely costly, with time and mice very expensive (Long 
et al., 2010).  Many groups have started to move towards more in vitro (e.g. ToxCast) models 
for their high throughput nature, however in vitro models cannot answer most physiological 
questions (Dix et al., 2007).  A critical need in gerontologic research is an understanding of 
how host genetics and environmental exposures interact over the organismal lifespan to 
produce common phenotypes of aging such as increased risk to certain diseases, loss of 
regenerative capacity and frailty.  
Aging and Senescence 
 Mammalian aging results from multiple distinct processes and it is unlikely that any 
single pathogenic pathway accounts for all aspects of aging.  While disparate molecular 
pathways surely contribute, several lines of evidence suggest the activation of cellular 
senescence is an important contributor to many age associated conditions.  Moreover, the 
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accumulation of senescent cells in vivo appears to be measurable, providing a means to 
determine if a noxious exposure or toxicant accelerates this aspect of aging.  This research 
will give us insight to the mechanisms of aging after toxicological exposure.  
Cellular Senescence and p16
INK4a
 Expression  
 Senescence is the state at which cells stop dividing and reach their proliferative 
capacity, known as the Hayflick limit (Hayflick and Moorhead, 1961).  There are specific 
factors that define a senescent phenotype, as reviewed in (Rodier and Campisi, 2011).  These 
factors include, but are not limited to: a permanent growth arrest, an enlarged cellular size, 
altered gene expressions (p21
CIP
, p16
INK4a
, C-fos, PCNA), increase SA-β-galactosidase (SA 
β-gal) staining, and senescence associated secretory phenotype (SASP) (Figure 1). Even 
though these cells do not replicate, they remain metabolically active.  Recent evidence has 
shown that cellular senescence is supplemented with a marked increase in the secretion of a 
wide-range of factors including, proteases, chemokines and cytokines, most known to 
stimulate inflammation, known as SASP.  Many components can influence cellular 
senescence.  Factors that cause senescence include telomere shortening, induction of 
oncogenes (Serrano et al., 1997; Zhu et al., 1998), oxygen radicals (Chen et al., 2004), DNA 
damage (Bartkova et al., 2006; Meng et al., 2003), and epigenetic silencing (Chen et al., 
2009). For example, prior in vivo work has shown that whole body ionizing radiation, a 
known damaging agent, will lead to senescence in the hematopoietic stem cells (Wang et al., 
2006).  Furthermore, mounting evidence has shown that a known tumor suppressor, p16
INK4a
, 
is not only a mediator of senescence after exposure (e.g. ionizing radiation) but also a 
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biomarker for aging (Janzen et al., 2006; Krishnamurthy et al., 2006; Krishnamurthy et al., 
2004; Liu et al., 2009; Molofsky et al., 2006). 
 p16
INK4a
 is a cell cycle inhibitor and part of the retinoblastoma protein (RB) pathway 
along with other RB-family proteins (p107, p130).  In a normal cycling cell, cyclin 
D/CDK4/6 complex will bind to the RB protein, allowing RB to hyperphosphorylate.  The 
hyperphosphorylated RB protein will then release the E2F transcription factor.  Once the E2F 
transcription factor is released, the cell will move from the G1 to S phase of the cell cycle.  
When p16
INK4a
 is activated, the protein will physically block cycle D from binding to 
CDK4/6, causing RB to stay bound to E2F.  Without the release of E2F, the cell will pause 
between G1 to S phase (Figure 2).  It is still unclear how the cell decides move from a 
quiescent (transient growth arrest) to senescent state (permanent growth arrest).  Recent 
discoveries have given insight as to the regulators of p16
INK4a
.  One group has should that 
p16
INK4a
 locus is H3K27-methylated and bound by BMI1, RING2, and SUZ12 leading to 
transcriptional repression of the transcript (Kotake et al., 2007).  Others have shown that 
EZH2 is down-regulated in senescing cells, along with displacement of BMI1, and activation 
of p16
INK4a
 expression (Bracken et al., 2007).  Additionally, through downregulation of 
p16
INK4a
 and ARF, overexpression of BMI-1 will lead to fibroblast immortalization, and with 
the addition of H-ras activation it will lead to malignancy in mice (Jacobs et al., 1999).  
Lastly, prior work has demonstrated that in senescent cells, the increase in p16
INK4a
 
expression is correlated with the decrease of Id1 and accumulation of Ets1 (Ohtani et al., 
2001).  While the immediate upstream transcription factors have been discovered, however, 
relationship between environmental exposure and modulation of transcription factors remains 
unclear.  Even though the research has made tremendous advances in understanding the 
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molecular mechanisms of p16
INK4a
 regulation with respect to cancer and aging, there are still 
many questions that need to be answered. 
 In vitro, p16
INK4a
, along with other proteins including ARF, is strongly associated 
with senescence.  Prior work has shown that oxidative stress of many primary mammalian 
cell types, including WI38 (human fibroblasts) and mouse embryonic fibroblasts (MEFs), 
will lead to the induction of p16
INK4a
, and eventually lead to senescent state.  
Consequentially, if p16
INK4a
 is suppressed, the cells will transform allowing for infinite 
passages, a neoplasmic phenotype.  This same phenotype has been shown with ARF, a 
similar cell cycle regulator located along with p16
INK4a 
on the CDKN2A locus (Matheu et al., 
2008).  Additionally, when cells are transformed with an oncogene (termed ‘oncogene 
induced senescence’), there is a robust induction of cells cycle inhibitors including p16INK4a, 
further validating the relationship between p16
INK4a
 and senescence.  Moreover, cells with 
high levels of p16
INK4a
 are shown to be cancer resistant (Matheu et al., 2004). By preventing 
proliferation of a cell harboring DNA damage or oncogene activation, the senescence 
pathway is a pivotal tumor suppressor mechanism. (Campisi and d'Adda di Fagagna, 2007; 
Sager, 1991). 
Organismal Aging 
 p16
INK4a
-mediated senescence is currently believed to contribute to mammalian 
organismal aging through at least two mechanisms.  First mechanism is through senescence-
mediated loss of replicative capacity at the level of the tissue stem cell.  This loss leads to 
impaired homeostasis and regenerative capacity in response to stressors including DNA 
damage and oncogene activation (Sharpless and DePinho, 2007). Initially findings showed 
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that senescent cells accumulate with aging in vivo (Dimri et al., 1995).  Moreover, activation 
of p16
INK4a
 and senescence has been linked to replicative hypofunction in several tissues (i.e. 
neural stem cells (Molofsky et al., 2006), hematopoietic progenitors (Janzen et al., 2006), 
lymphocytes (Liu et al., 2009; Signer et al., 2008), and pancreatic  β-cells (Krishnamurthy et 
al., 2006)). Notably, this replicative hypofunction that comes with increased p16
INK4a
 
expression with aging is markedly attenuated in the absence of p16
INK4a
 suggesting a causal 
relationship.  Further evidence that the senescence pathway plays a vital rule in human aging 
includes correlation of senescence associated markers (e.g. p16
INK4a
, COX-1, COX-2, SA β-
gal) expression with chronological age in skin, kidney, and PBTLs (Dimri et al., 1995; Liu et 
al., 2009; Melk et al., 2004).  Prior Altered regulation of the senescence promoting 
CDKN2a/b locus, which encodes p16
INK4a
, p15
INK4b
 and ARF, has been linked to age-
associated phenotypes including atherosclerotic disease, type II diabetes, glaucoma and 
several malignancies (Jeck et al., 2012).   
 The second mechanism whereby senescence may contribute to phenotypic aging may 
be through the effector molecules of SASP.  More specifically research has demonstrated that 
the release of Il-6, a marker for inflammation, has been shown to increase in senescence cells 
(Freund et al., 2010; Grivennikov et al., 2009; Hodge et al., 2005; Kuilman et al., 2008).  In 
vivo, many SASP factors including Il-6, Il-10, Il-8, Il-1a, Groα, are associated with both lack 
of cellular regeneration and hyperproliferation in mice and humans (Coppe et al., 2010; 
Davalos et al., 2010; Liu et al., 2009).  In fact, SASP factors have been shown to promote 
tumorigenesis in some cancers including mammary (Krtolica et al., 2001), melanoma (Lazar-
Molnar et al., 2000), and prostate (Yang et al., 2005).  These similarities may be due to the 
common low-grade inflammation found during both aging and tumorigenesis (Bruunsgaard 
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et al., 2001).  Pharmacologic and genetic approaches to manipulate the number of senescent 
cells in vivo can ameliorate age-associated phenotypes such as sarcopenia, kyphosis, and 
hypo-replication of T-lymphocytes and pancreatic β-cells (Berent-Maoz et al., 2012; Chen et 
al., 2011a; Zindy et al., 1997).  One group has generated a murine model that allows drug-
inducible elimination of p16
Ink4a
-positive senescent cells. After induction, the tissues (e.g. 
adipose, skeletal muscle and eye) that have p16
INK4a
-dependent age-related disease have 
delayed onset of these phenotypes with removal of p16
INK4a
-expressing cells (Baker et al., 
2011). 
The Science of Biological Aging 
 Historically, there has been immense effort to understand the genetics of aging across 
species.  Many transcription factors found in  Caenorhabditis elegans (C. elegans) have been 
shown to promote longevity including HSF-1 and DAF-16 (Hsu et al., 2003).   Additionally, 
extended lifespan of Drosophila melanogaster (Drosophila) is exhibited after overexpression 
of protein carboxyl methyltransferase (PCMT), a protein repair enzyme (Chavous et al., 
2001).  Collaboratively, comparative analysis of DNA microarray experiments has shown a 
common pattern of aging regulation among species including C. elegans and Drosophila 
(McCarroll et al., 2004).  In murine models, there has been immense work to affect lifespan 
through genetically manipulation.  Some of these alleles include, the ‘little mouse’ 
(Ghrhr
lit/lit
), mice null for either growth hormone receptor/binding protein (GHR/BP
−/−
) or 
p66shc (p66shc
−/−
), mice heterozygous for the IGF-I receptor (Igf1r
+/−
), and fat-specific 
insulin receptor knockout mice (Liang et al., 2003).  Human studies have also a genetic link 
with lifespan.  Genome-wide associated studies indicate that SNPs in the insulin/insulin-like 
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growth factor signaling (IIS) pathway and the telomere maintenance (TM) pathway are 
associated with human longevity (Deelen et al., 2013).  Aging genetics has been well-
established; however there are still answers that are necessary for understanding environment 
effects of aging. 
 Some aspects of toxicological aging, including DNA damage and diet, have been 
studied in species other than mammals, such as Danio rerio (zebrafish).  For example, 
reactive oxygen species (ROS) formation induced by copper exposure is responsible for the 
increase in DNA repair gene expression, a known effector of aging (Sandrini et al., 2009). 
Exposure of zebrafish larva to oarathyroid hormone resulted in net bone loss, another 
common age related disease (Fleming et al., 2005).  Additionally, long-lived zebrafish 
mutants show increase resistance to oxidative damage (Gruber et al., 2009). Dietary caloric 
restriction has shown to increase lifespan in many organisms including drosophila (Frankel et 
al., 2011), C. elegans (Gerhard and Cheng, 2002), and mice (Masoro, 2000; Sohal et al., 
1994).  The minimal work that has been done in mammals has largely focused on the 
pharmacology of aging.  Rapamycin, an inhibitor of the mTOR pathway, has been shown to 
extend the lifespan of mice when given later in life (Harrison et al., 2009).  Rapamycin 
treated mice also show slower age-related changes in heart, liver, adrenal glands, 
endometrium, and tendons (Wilkinson et al., 2012).  The National Institute on Aging's 
Interventions Testing Program has completed a study testing four candidate agents for 
potential aging-delaying compounds, in hopes to understand the mechanism of aging after 
environmental exposure.  Even though none were successful for extending lifespan, 
nordihydroguiaretic acid (NDGA) reduces early life mortality risks (Miller et al., 2007).  In 
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summary, there has been some work to show the relationship between exposures and aging in 
numerous species, however little research has been focused on mammalian aging toxicology.  
Gerontogens 
 In 1987, George Martin pointed out that the rate of aging is largely non-genetic 
(>50%), and coined the term "gerontogen" to describe an environmental agent that 
accelerates aging.  In response to gerontogen exposure,  phenotypic outcomes at the 
organismal level include the loss of proliferative homeostasis, the decline in the efficiency of 
enzyme adaptation, and immunodeficiency  (Martin, 1987).  Martin also discusses categories 
of environmental gerontogens including segmental gerontogens, which affect multiple 
senescent phenotypes, and unimodal gerontogens which affect only a specific tissue or organ.  
Environmental exposures (or therapeutic exposures such as radiation and chemotherapy) act 
as gerontogens when they lead to cellular insults that induce, what is now considered, cellular 
senescence (e.g. DNA damage or increasing reactive oxygen species). According to this 
theory, differential exposure to gerontogens may underlie the marked phenotypic variation in 
human physiological aging (Figure 1).   
High Fat Diet  
 Research has shown that high fat diet can lead to certain age related diseases 
including diabetes, atherosclerosis, and cancer in both humans and mice, making it a 
potential gerontogen (Giovannucci and Goldin, 1997; Purcell-Huynh et al., 1995; Schulze et 
al., 2004; Tannenbaum, 1942; Winzell and Ahren, 2004; Xu et al., 2001).  Specifically, lack 
of cellular proliferation is seen in the pancreatic β-cell in high fat induced diabetic mice 
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(Sone and Kagawa, 2005).  Additionally, prior studies on the effects of obesity and high fat 
diet (HFD) on p16
INK4a
 expression, a cell cycle inhibitor and known marker for senescence, in 
vivo have given very tissue specific results. For example, HFD has been reported to increase 
senescence and p16
INK4a
 expression in the murine aorta (Wang et al., 2009), whereas p16
INK4a
 
mRNA expression in peripheral blood T-lymphocytes (PBTL) does not correlate with body-
mass index, a marker of obesity, in humans (Liu et al., 2009).  High fat diet can be 
considered a gerontogen, however the mechanism of its advanced aging phenotype, is less 
certain.  It is well known that fat causing an induction of reactive oxygen species, which can 
lead to a senescent phenotype (Tchkonia et al., 2010).  One question that remains 
unanswered is which senescent pathway leads to the advanced aging phenotype in vivo. 
Arsenic 
 Arsenic is a non-DNA damaging gerontogen.  It is a common toxicant found in 
ground water that has been linked to age-related phenotypes including cancer (e.g. skin, 
bladder), type II diabetes, and atherosclerosis (Kapaj et al., 2006).  Others have shown that 
arsenic among other heavy metals can leads to many age-related neurodegenerative diseases, 
including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and Ataxia 
telangiectasia (Migliore and Coppede, 2009).  While genetic background plays a role with 
some of these neurodegenerative disorders, exposures to arsenic can accelerate the 
pathology. 
 While arsenic does not directly damage DNA, there is substantial evidence that 
arsenic induces oxidative genotoxicity as well as hinders that function of DNA repair 
machinery (Andrew et al., 2003; Hartwig et al., 1997; Yamauchi et al., 2004).  In mice, there 
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are more of 8-hydroxy-2'-deoxyguanosine (8-OHdG) adducts, a marker for oxidative DNA 
damage, in the brain of mice that were exposed to as little as 1 or 2 ppm of arsenic, which 
lead to degeneration of the cerebral and cerebellar cortexes (Piao et al., 2005).   In humans, 
there is a positive association between arsenic concentrations in whole blood with the level of 
reactive oxidants in plasma (Wu et al., 2001).  In both rodents and humans, arsenic decreases 
the functionality of DNA repair machinery.  One study completed in rats, shows that after 
exposure to sodium arsenite, rats were challenged with benzo(a)pyrene to promote DNA 
damage repair.  The results show that rats exposed to the arsenic incorporated less 
32
P, 
suggesting a slower efficiency of DNA repair (Tran et al., 2002).  Studies in humans show 
similar results.  One study measured a cohort of citizens from West Bengal, India, a common 
hot spot for high levels of arsenic in the drinking water. DNA damage and chromosomal 
aberrations were found to be significantly higher in the arsenic-exposed individuals 
compared to unexposed individuals.  Additionally, the challenge assay showed that upon 
induction of DNA damage, the repair capacity in the exposed individuals with premalignant 
hyperkeratosis is significantly less than that of individuals without skin lesion within the 
arsenic exposed group (Banerjee et al., 2008).  Another study showed that arsenic exposure 
was associated with decreased expression of ERCC1, a known protein involved in nucleotide 
excision repair, in lymphocytes from a cohort in New Hampshire, USA and Sonora, Mexico 
at the mRNA and protein levels (Andrew et al., 2006).  The gerontogenic effects of arsenic 
may be due to the induction of oxidative DNA damage as well as the decrease in DNA 
damage repair efficiency. 
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UV Light 
 Ultraviolet light is a potential unimodal gerontogen since almost all age-related 
pathologies are associated with the skin.  There is strong evidence to correlate the effects of 
UV leading to photoaging and skin cancer (Kligman, 1989; Scharffetter-Kochanek et al., 
2000).  Additionally, prior work has suggested that acute UVB exposure can rapidly induce 
senescence in human skin (Pavey et al., 1999).  Others have also shown that chronological 
aging and photoaging share basic molecular mechanisms including inductions of cytokines, 
ROS, UV-associated transcription factors (e.g. AP-1).  Moreover, UV-induced ROS cause 
negative effects on cellular components including DNA, proteins, lipids, which is similar to a 
chronological aging phenotype (Fisher et al., 2002).   
 There is substantial evidence showing how UV light causes direct DNA damage.  As 
far back as 1966, research has shown that UV light leads to pyrimidine dimers in DNA 
(Setlow and Carrier, 1966).  Others show that the DNA damage can cause changes in age-
related markers including the induction of SASP factors (Il-6, NFκB) (Freund et al., 2011; 
Rodier et al., 2009), and tumor suppressor genes (p16
INK4a
, ARF, p53) (Bartkova et al., 2006; 
Lakin and Jackson, 1999) as well as a strong relationship between the mechanisms of age 
related telomere decay and DNA damage checkpoint (d'Adda di Fagagna et al., 2003).   In 
addition to direct DNA damage, UV light, specifically UV-B light, causes ROS-associated 
DNA damage potentiating the aging phenotype (Cadet et al., 2005; Wei et al., 1998).  Both 
indirect and direct DNA damage are responsible for the gerontogenic properties of UV light. 
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Cigarette Smoke 
 One common segmental, or multifaceted, gerontogen is cigarette smoke.  Exposure to 
both primary and secondary smoke can lead to a vast array of aging phenotypes, which 
include advance aging of the skin, bones, and teeth as well as deleterious effects of the 
reproduction, cardiac, and pulmonary systems, and extensive cancers to the head, neck, and 
lungs (Bernhard et al., 2007).  In addition to its well-known impact upon various types of 
neoplasms, it also had deleterious effects upon reproduction, the cardiovascular and 
pulmonary systems, skin, and bone diseases such as emphysema, atherosclerosis and several 
cancers (Bernhard et al., 2007; Ito and Barnes, 2009).  The relationship with chronological 
age was much more striking, but it remains to be seen if there is any causal relationship to 
mechanisms of aging.   
 The mechanism of action for cigarette smoke is very complex, due to the extensive 
amount of chemicals found in a cigarette, including formaldehyde, carbon monoxide and 
nicotine.  Research shows that mutagens in cigarette smoke promote DNA damage 
(DeMarini, 2004; Pfeifer et al., 2002) as well induce neurodegeration (Slikker et al., 2005), 
which are also potential mechanisms of gerontogenesis.  More specifically, both 
formaldehyde and nicotine can accumulate in the brain leading to an age-dependent cognitive 
decline in rats (Belluzzi et al., 2004; Tong et al., 2013).  Additionally, cigarette smoke led to 
decreased exhaled nitric oxide, suggesting a potential mechanism for age-related increased 
risks of chronic respiratory and cardiovascular disease in cigarette smokers (Kharitonov et 
al., 1995).  In humans, our group and others have shown chronic cigarette smoke exposure in 
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humans is associated with increased p16
INK4a
 expression and shorter LTLs in PBTL (Liu et 
al., 2009; Mirabello et al., 2009; Nelson et al., 2012; Song et al., 2010; Valdes et al., 2005). 
Measuring aging and senescence 
 Some of the markers of cellular senescence that increase with aging in humans and 
mice include SA β- galactosidase staining [48], SASP factors [49], telomere foci [50], and 
expression of the p16
INK4a
 tumor suppressor gene [13, 46, 51, 52] (Table 1).  While all have 
shown an increase in specific experiments, very few are substantial, global, consistent, 
increase in many organs over time.  Historically, SA β-galactosidase staining has been used 
to measure senescence, since senescent cells have been shown to have higher levels of 
endogenous β-galactosidase expression due to a lower pH.  In vitro, this marker is very 
consistent; however in vivo interpretation can be difficult.  Since SA β-gal stain is based on a 
change in pH, the differences in pH can change between tissues as well as throughout a 
singular tissue, making the results convoluted.  SA β-gal stain is also poorly suited as a 
longitudinal translational measure of aging because of the requirement for end-organ 
staining.  In murine studies the animal needs to be sacrificed for proper analysis, and human 
studies are not feasible with rare exception because of need to biopsy.   
 In humans, telomere length has been associated with chronological age.  For example, 
decreased leukocyte telomere length (LTL) has repeatedly found to be inversely correlated 
with chronological age, anticipated 25 basepairs per year (Chen et al., 2011b; Lin et al., 
2010).  Further, average LTL is shorter in people with known exposure to gerontogens 
including cigarette smoking and obesity (Mirabello et al., 2009; Song et al., 2010; Valdes et 
al., 2005).  Unfortunately, LTLs are difficult to use as a biomarker for in depth studies since 
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confounding factors of physiological aging in humans make it difficult to control. First, 
despite the long held conception that telomere length is a marker for residual replicative 
capacity (e.g. cells with shortened telomeres will not be able to replicate), there is little 
evidence to substantiate that hypothesis in humans (Longo, 2009).   In fact, in one of the 
most highly replicative organs the bone marrow in which aging is known to lead to marrow 
dysfunction, LTL does not predict circulating levels of leukocytes, erythrocytes or platelets, 
therefore does not predict the replicative capacity of their progenitors(Mollica et al., 2009).  
Second, while telomere length will decrease across the lifespan in population-based studies, 
LTL varies substantially among individuals of the same age, and the absolute change is 
relatively small over an organism’s lifespan it is unlikely to be a reliable aging biomarker 
(Longo, 2009; Muezzinler et al., 2013; Valdes et al., 2005).  Additionally, the methods for 
determining LTL are difficult and expensive, making it less appealing as a high throughput 
biomarker.   
 IL-6, a pro-inflammatory cytokine, is also associated with aging.  In large cohort 
studies, IL-6 increases with age. IL-6 is implicated causally in the aging process as the cause 
of a chronic inflammatory state that leads to age-associated debility (Hager et al., 1994; 
Maggio et al., 2006).  In addition, elderly individuals with physical frailty and disability have 
higher IL-6 than those with lower levels (Cesari et al., 2004; Cohen et al., 1997; Taaffe et al., 
2000).  Despite these associations, IL-6 is poorly suited as a biomarker of physiological age 
in studies of potential gerontogens.  In healthy adults IL-6 is commonly either below or at the 
lower limits of detect, yet dramatically increases during acute illness, making LTL levels 
extremely variable.  IL-6 also has strong cyclical associations with the circadian rhythm 
(Ershler and Keller, 2000; Maggio et al., 2006).  IL-6 may be a key part of a chronic 
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inflammatory milieu that causes physical decline with aging, but it is poorly suited as an 
outcome measure of the effect of environmental exposures on aging in humans. 
 Expression of p16
INK4a
 in PBTLs has been shown to a faithful biomarker for 
chronological age, due to a stable, dynamic increase over a lifespan, in many different organs 
in both humans and mice [13, 52](Table 1).  Because of the ability to measure p16
INK4a
 in 
people with the CD3+ T-lymphocyte assay, these exposures can be evaluated in people.  In 
humans, known DNA damaging chemotherapy treatments lead to higher levels of p16
INK4a
 
expression in the T cells of patents after treatment.  While there are some limitations for 
p16
INK4a
 expression including difficultly to solate T-lymphocytes, this biomarker seems to be 
a promising candidate for in clinic evaluation of aging.   
Measuring toxicological aging in vivo 
 Recently, a new p16-luciferase (p16
LUC) allele developed in Norman Sharpless’ lab, 
allowing the field of aging to begin testing the rate of aging in vivo, while decreasing cost 
and time, thus opening the door to a promising biomarker for in vivo testing after exposure to 
gerontogens.  For this allele, firefly luciferase is knocked into exon 1α immediately after the 
start codon in the Cdkn2a locus.  With the knock-in specific to exon 1α, the ARF construct, 
which consists of exon 1β, 2, and 3, remains functional.  The Sharpless group has published a 
paper, showing the reporter allele faithfully measuring in vivo induction of p16
INK4a
 in 
correlation with chronological age (Burd et al., 2013)(Figure 3).  The major benefit of this 
allele is that the mice can be serially imaged decreasing cohort size, while gathering data at 
an individual level.  Others have shown that caloric restriction and exercise are known to 
decrease the rate of aging over time, specifically p16
INK4a
-associated gerontogens, such as 
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cigarette smoke, induce p16
INK4a
 expression at a faster rate when compared to non-exposed 
cohorts in both human PBTLs and whole mice (Krishnamurthy et al., 2004; Liu et al., 2009).  
Specifically, p16
INK4a
 increases at a faster rate over time in chronic smokers when compared 
to both former and non-smokers in human PBTL (Liu et al., 2009).  In mice, p16
INK4a
 
expression is much higher in the upper respiratory region after four months of exposure to 
low chronic dose of cigarette smoke.  Using the p16
LUC
 mice, other gerontogens enhance the 
p16
INK4a
-associated aging rate include UV light and to a lesser extent arsenic, further 
confirming the value of this reporter allele. 
 Aging is a dynamic, complex process that encases many mechanistic pathways, 
making it challenging to objectively measure.  Further, the field of aging has made great 
progress in understanding the genetics of aging, but to a lesser extent the toxicological effects 
of aging.  My work uses a novel allele to quantitatively measure p16
INK4a
 associated aging in 
an unbiased manner.  Moreover, my work contributes to mechanistically understanding how 
environmental exposures can lead to an advanced aging phenotype. 
  
17 
 
 
Figure 1.1: Summary demonstrating known gerontogens, mechanistic inducers of 
senescence and biomarkers of a cellular senescent phenotype 
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Figure 1.2: Schematic of p16
INK4a
 transcriptional regulation 
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Figure 1.3: Increased expression of p16
INK4a
 , or increased luminescence signal, in 
p16
LUC
 aging mice demonstrating the relationship between p16
INK4a
 and aging in vivo.   
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Table 1: Summary of the strengths and weaknesses of aging biomarkers 
 
  
 
 
CHAPTER 2:  GERONTOGEN TESTING IN p16
LUC
 REPORTER MICE 
2.1 Introduction 
 Murine models have played a critical role in the identification and classification of 
carcinogens.  For example, commercially available animal models, (i.e. BigBlue
TM
, 
MutaMouse
TM 
and the p53
+/-
 strain) (Goldsworthy et al., 1994; Jacobson-Kram et al., 2004; 
Long et al., 2010), comprise core tools in cancer toxicological assessment. These reagents 
have enhanced our basic understanding of carcinogenesis, and have contributed to public 
health by increasing the efficiency and sensitivity of carcinogen identification while reducing 
animal requirements and research costs.  In 1987, George Martin proposed the concept of 
“gerontogens” (Martin, 1987); that is, environmental agents which accelerate molecular 
aging analogous to the way carcinogens accelerate neoplasia.  While murine models for 
carcinogen testing are advanced, in vivo tools for gerontogen testing do not exist. 
 Mammalian aging is complex, with several distinct molecular processes contributing 
to age-related tissue dysfunction and morbidity.  While no single molecular process 
underpins all aspects of mammalian aging, several lines of evidence suggest the activation of 
senescence is an important contributor to aging.  Markers of cellular senescence dramatically 
increase with aging in humans and mice, including expression of the p16
INK4a
 tumor 
suppressor gene (Krishnamurthy et al., 2004; Liu et al., 2009; Nielsen et al., 1999; Zindy et 
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al., 1997).  Moreover, activation of p16
INK4a
 and senescence has been linked to replicative 
hypofunction in several tissues (i.e. neural stem cells (Molofsky et al., 2006), hematopoietic 
progenitors (Janzen et al., 2006), lymphocytes (Liu et al., 2011; Signer et al., 2008),  and 
pancreatic  beta-cells (Krishnamurthy et al., 2006)).  Altered regulation of the senescence 
promoting CDKN2a/b locus, which encodes p16
INK4a
, p15
INK4b
 and ARF, has been linked to 
age-associated phenotypes including atherosclerotic disease, type II diabetes, glaucoma and 
several malignancies (Jeck et al., 2012). Finally, pharmacologic and genetic approaches to 
manipulate the number of senescent cells in vivo can ameliorate age-associated phenotypes 
such as sarcopenia, kyphosis, and hypo-replication of T-lymphocytes and pancreatic beta-
cells (Baker et al., 2011; Berent-Maoz et al., 2012; Chen et al., 2011a).  Given these intimate 
links between aging, p16
INK4a
 expression, and senescence induction, we sought to determine 
if in vivo activation of p16
INK4a
, measured through the use of a recently described reporter 
allele (Burd et al., 2013), could be used to assess the gerontogenic effects of environmental 
agents.   
 
2.2 Materials and Methods 
 Experiments were performed under protocols approved by the institutional care and 
use committee (IACUC) of the University of North Carolina. Hairless SKH1-E p16
LUC/+
 
mice were used for all experiments.(Burd et al., 2013) Genotyping was performed as 
previously described.(Burd et al., 2013)   For histologic analysis, tissues were fixed with 10% 
formalin overnight, and then transferred to 70% ethanol for paraffin blocking and staining.  
All slides were generated and stained with Hematoxylin and Eosin at the UNC 
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Histopathology Core.  Quantitative TaqMan RT-PCR strategies for the detection of p16
INK4a
 
were performed as previously described (Krishnamurthy et al., 2006; Krishnamurthy et al., 
2004).  Statistical significance was determined using a student’s t-test or linear regression 
analysis for all comparisons except survival analysis, where the Gehan-Breslow-Wilcoxon 
test was employed.   
2.2.1 Exposures 
High Fat Diet:  42% Fat diet (HFD) was ordered from Harlan Laboratories (TD.88137).  At 
8-10 weeks of age, mouse chow was changed to HFD vs. normal diet (4% fat) after initial 
baseline imaging.  New diet was refilled once a week.  Twenty male and female SKH1-E 
p16
+/LUC
 mice were analyzed per dietary cohort (42% vs. 4%) for 84 weeks. 
Hepatic Steatosis Evaluation: Livers were incubated in 4% Osmium overnight, washed with 
diH2O, and then fixed with 10% Formalin.  Tissues were then imbedded, sectioned and 
stained with Hematoxilyn and Eosin using the Immunohistochemistry core facility. 
Data Analysis: Linear regression analysis was completed to determine the relationship 
between p16
LUC
 signal and weight in HFC cohort at 52 weeks of exposure. 
Arsenic: Sodium arsenite (As) was ordered from Sigma (71287-250G) and dissolved in 
sterile water at 50 ppm.  At 10-12 weeks of age, mouse water was changed to 50 ppm vs. 0 
ppm arsenic after initial baseline imaging.  New water was refilled once a week.  Twenty 
male and female SKH1-E p16
+/LUC
 mice were analyzed per arsenic cohort (50 ppm vs. 0 
ppm) for 48 weeks. 
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Pancreatic Islet Measurements: Randomized 10x histological images were taken of the 
pancreas in each cohort.  Each islet was then carefully traced and the area was measured 
using imageJ analysis. 
Cigarette Smoke: Cigarettes were ordered from the University of Kentucky (3R4F)—through 
the Reference Cigarette Program at College of Agriculture in Lexington, Kentucky.  
Beginning at age 10-12 weeks after baseline imaging, mice were exposed to one hour of 
cigarette smoke/day, five days/week.  For exposure, mice were put into an inExpose 
exposure system providing both mainstream and side stream smoke exposure.  Control 
animals (no smoking exposure) were handled in an identical manner except were not exposed 
to tobacco smoke.  Ten male SKH1-E p16
+/LUC
 mice were analyzed per tobacco cohort 
(smoking vs. non-smoking).  Animals were exposed to tobacco smoke for 24 weeks, but 
were imaged for an additional 32 weeks after exposure. 
UV light: A UVB lamp from UVP was used for these studies, with an emission spectrum of 
290-350 nm light, and with a peak emission at 312 nm.  At 8-10 weeks of age, mice were 
exposed to 353 J/m
3
 of UVB light three times per week for 24 weeks. UV exposure began 
after initial baseline imaging.  Fifteen male SKH1-E p16
+/LUC
 mice were analyzed per UVB 
cohort (exposed vs. unexposed) for 16 more weeks after exposure. UV exposed mice were 
sacrificed for morbidity or tumor burden in accordance with established laboratory protocols. 
Phospho-Histone H2A.X Immunohistochemistry: Skin tissues were incubated overnight with 
1/500 of Phospho-Histone H2A.X (Ser139) (20E3) Rabbit mAb (Cell Signaling Cat # 9718) 
according to Cell Signaling standard immunohistochemistry instructions.  
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Data analysis:  All H2AX cells in the epithelial layer of the exposed skin were divided by the 
total number of epithelial cells in the microscopic field.  Fisher’s exact test was used to 
determine statistical significance. 
Senescence-Associated ß-galactosidase (SA-ß-gal) activity: Skin was assayed using Cellular 
Senescence Assay Kit (KAA002; Millipore, USA) according to manufacturer's instructions. 
2.2.2 In vivo Luminescence Imaging 
Luciferase Imaging: To serially monitor luciferase induction, mice were imaged as 
previously described (Burd et al., 2013) using a Xenogen IVIS LUMINA/KINETIC Imaging 
System.  Imaging was completed under anesthesia, immediately after D-luciferin injection 
(10 mg/ml in sterile PBS). Sequential imaging was used to determine optimal luminescence.  
A sequence of 2 min, 2 min, 2 min, 2 min, 30 sec, and 1 min were used.  The 4
th
 two minute 
image (8 minutes after initial injection) was used for all reported imaging measurements.  For 
arsenic, high fat diet, and cigarette smoke exposure images were taken of the ventral side of 
the mouse.  For UV light, the dorsal (exposed) and ventral (unexposed) sides of each mouse 
were taken.  Living Image 3.1 Software (Caliper Life Sciences) was used to analyze the 
images at the same image exposure time point (8 min) over the life span of the mouse.  
Representative images are shown with exposed and unexposed animals for each cohort, as 
well as appropriate imaging scales to account for imaging settings.   
Data Analysis: The raw average radiance values (photon/sec/cm
2
/steradian) from the original 
images were used.  A wide angle lens (FOV-24) was used to capture images of 3 or more 
mice. For each exposure, mice were imaged at least every other month for up to one year, 
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although some animals were imaged more frequently during the initial stages of each 
exposure period.  Each mouse was circled to measure average radiance values (p/s/cm
2
/sr) 
over the region of interest.  The area for each mouse was held constant for each experiment.  
A blank area on the image was also circled to allow for subtraction of background noise.  To 
omit background noise from each individual mouse image, the background circle was 
subtracted from the mouse circle.  To graph the luciferase induction over time, all murine 
luciferase signals in a specific cohort were averaged at time zero and normalized to a value of 
one.  All subsequent mouse images were then normalized relative to the average time zero 
luminescence. 
 
2.3 Results 
 The p16
LUC 
allele features firefly luciferase ‘knocked-in’ to exon 1α of the murine 
Cdkn2a locus, which includes the p16
INK4a
 transcriptional start site (Burd et al., 2013).  This 
allele places luciferase under the control of the endogenous p16
INK4a
 promoter as well as cis-
regulatory elements, which are known to extend for several hundred kilobases around the 
locus (Burd et al., 2010; Visel et al., 2010).  Importantly, expression of p16
INK4a
 is negligible 
in healthy cells from young mice, but accumulates with age-promoting stresses, and 
subsequent senescence.  Additionally, cellular expression of p16
INK4a
 increases more than 
300-fold on a per cell basis (Burd et al., 2013; Krishnamurthy et al., 2004).  This large, 
dynamic range of p16
INK4a
 expression makes p16
LUC
 a valuable tool for in vivo imaging of 
senescence induction.  To assess the impact of candidate gerontogens (i.e. high fat diet, UV 
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light, arsenic, and cigarette smoke) on senescence, we performed serial analysis of p16
LUC
 
cohorts.  Hairless SKH1-E mice were used for all studies to further enhance in vivo imaging.   
2.3.1 High Fat Diet  
 Prior studies on the effects of obesity and high fat diet (HFD) on p16
INK4a
 expression 
in vivo have yielded inconsistent results. For example, HFD has been reported to increase 
senescence and/or p16
INK4a
 expression in the murine or baboon vascular cells (Shi et al., 
2007; Wang et al., 2009), whereas p16
INK4a
 mRNA expression in peripheral blood T-
lymphocytes (PBTL) does not correlate with body-mass index, a marker of obesity, in 
humans (Liu et al., 2009).  To explicitly examine the effects of high fat diet on whole body 
senescence in vivo, littermate p16
LUC 
mice were placed on a 42% (HFD) or 4% fat diet 
(normal diet, ND) for 18 months starting at 8-10 weeks of age.  HFD produced a clear 
pharmacodynamic effect, causing significant weight gain (Supplemental Figure 2.1A) and 
hepatic steatosis (Supplemental Figure 2.1B).  Overall survival was not significantly different 
between the HFD and ND cohorts (Supplemental Figure 2.1C).  Consistent with prior reports 
(Burd et al., 2013; Krishnamurthy et al., 2004), we observed an exponential increase in 
p16
INK4a
 expression with aging, however the rate of increase in p16
INK4a
 expression assessed 
by total body luciferase imaging (TBLI) was not different for animals fed on a HFD versus 
ND (Figures 2.1, A and B).  Due to the wide range of weight gain among the mice on HFD, 
we analyzed the relationship between weight and luciferase intensity at 52 weeks and 
observed no correlation (Supplementary Figure 2.1D).  Correspondingly, expression of 
p16
INK4a
 mRNA was not altered in liver and spleen harvested from 18-month old mice fed 
HFD versus ND (Supplementary Figure 2.1E).  These data suggest that HFD does not 
28 
 
accelerate the accumulation of senescent cells in vivo, at least to the level of sensitivity of 
luciferase detection. 
2.3.2 Arsenic 
 Arsenic is a common environmental toxicant that has been linked to phenotypes 
associated with human aging (i.e. several cancers, type II diabetes and atherosclerosis) 
(Kapaj et al., 2006).  While not a direct clastogen, arsenic induces oxidative genotoxicity, 
and may decrease DNA repair (Andrew et al., 2003; Hartwig et al., 1997; Yamauchi et al., 
2004).  We examined the effect of chronic arsenic exposure on p16
INK4a
 expression in vivo.   
For this experiment, littermate p16
LUC
 mice were given 50 ppm arsenic or 0 ppm arsenic in 
the drinking water for 12 months starting at 8-10 weeks of age.  After 48 weeks of exposure, 
mice on 50 ppm arsenic had an average of 1.5 ppm arsenic accumulation in the liver as 
measured by mass spectrometry (Supplemental Figure 2.2A).  Consistent with the known 
effects of arsenic (Paul et al., 2007), mice on 50 ppm exhibited small, structurally deranged 
pancreatic islets (Supplemental Figure 2.2, B and C) with an extreme decrease in total islet 
mass (Supplemental Figure 2.2C), but overall survival rates were not altered with arsenic 
exposure (Supplementary Figure 2.2D).  Additionally, the exocrine portion of pancreas 
appeared normal in the exposed animals.  A modest, but significant increase in p16
INK4a
 
expression was observed by 24 weeks of exposure using TBLI (Figure 2.2, C and D) 
(p=0.023).  In accord with the TBLI results, expression of p16
INK4a
 mRNA was higher in 
spleen but not liver of one year old mice on 50 ppm versus 0 ppm arsenic (Supplemental 
Figure 2.2E). These data suggest that chronic arsenic exposure modestly accelerates the 
accumulation of senescent cells in vivo.    
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2.3.3 Cigarette Smoke 
 Research shows that mutagens in cigarette smoke promote DNA damage (DeMarini, 
2004; Pfeifer et al., 2002) and smoking promotes age-related diseases such as emphysema, 
atherosclerosis and several cancers (Bernhard et al., 2007; Ito and Barnes, 2009). Chronic 
cigarette smoke exposure in humans is associated with an increased p16
INK4a
 expression in 
PBTL (Liu et al., 2009; Nelson et al., 2012).  To determine the effects of moderate dose 
tobacco smoke exposure on cellular senescence in vivo, littermate p16
LUC
 mice were exposed 
to cigarette smoke (CS) or ambient air (AA) for one hour per day, five days per week for six 
months starting at 10-12 weeks of age. After six months of exposure, mice were aged without 
cigarette smoke for up to one year.  At the end of the one year study, histological analysis of 
the sinus cavity of CS mice showed particulate deposits along the epithelial layer of the nasal 
papilla in exposed animals, whereas no differences were noted in lung architecture between 
CS and AA cohorts at this tobacco dose (Figure 2.2A).  Additionally, this moderate tobacco 
dose was not associated with increased mortality (Supplemental Figure 2.3A).  There was a 
significant increase in p16
INK4a
 accumulation between the CS and AA cohorts as measured by 
TBLI which was readily noted within weeks of CS exposure, and persisted even after CS 
exposure was discontinued (Figure 2.2B).  Consistent with histologic examinations of the 
nasal cavities and lungs (Figure 2.2A), specific luciferase induction was noted in the head 
and neck region of mice, but not the thoracic and abdominal regions (Figure 2.2C).  
Correspondingly, p16
INK4a
 mRNA levels in the liver, lung, axillary lymph nodes and spleen 
were similar in one year old CS and AA mice (Supplemental Figure 2.3B).  These data 
suggest that low-dose, chronic CS exposure accelerates the accumulation of senescent cells 
in the tissues (i.e. nasal epithelium) that receive the highest exposure.    
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2.3.4 UV Light 
 Chronic UVB exposure causes photoaging and skin cancer (Kligman, 1989; 
Scharffetter-Kochanek et al., 2000).  Prior work has suggested that acute UVB exposure can 
rapidly induce p16
INK4a
 expression in human skin (Pavey et al., 1999).  To directly assess the 
effects of chronic UVB on the induction of senescence in vivo, the dorsal surface of p16
LUC
 
mice were exposed to 350 J/m
2
 of UVB light three times a week for six months starting at 
10-12 weeks of age.  Littermate control mice were contemporaneously aged in the absence of 
UVB.  After six months of exposure, mice were aged without further UVB exposure until 
they reached one year of age.  After six months of exposure, mice exposed to chronic UV 
light had more epidermal hyperkeratosis and metaplasia than the non-exposed cohort (Figure 
2.3A, upper panel).  The UV-exposed cohort exhibited more inflammatory infiltration into 
the reticular dermis and hypodermis of lymphocytes and neutrophils than non-exposed 
controls (Figure 2.3A, middle panel).  A marker of DNA damage, phospho-H2AX staining, 
was significantly increased in the epithelial layer of skin in UV exposed mice than non-
exposed mice, suggesting a persistent DNA damage response (Figure 2.3A, lower panel, and 
Supplemental Figure 2.4A).  Additionally, UVB exposed mice developed skin neoplasms 
starting five months into the window of exposure (Figure 2.3B) which were associated with 
increased mortality (Figure 2.3C).  Accumulation of luciferase was higher in p16
LUC
 animals 
treated with UV than unexposed controls prior to development of visible neoplasms and 
TBLI was almost ~8 times greater in UV-treated animals after 32 weeks of exposure (Figure 
2.3D).  In accord with the TBLI results (Figure 2.3E), p16
INK4a
 mRNA levels from abdominal 
and dorsal skin of one year old mice from both cohorts confirmed the site-specific induction 
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of 16
INK4a
 expression (Figure 2.3F).  Additionally, the UV exposed dorsal skin exhibited 
higher expression than unexposed abdominal skin from the same mouse (Figure 2.3F).   
 To confirm the induction of senescence in vivo using additional markers, we analyzed 
exposed and unexposed skin tissue for senescent associated (SA) cytokines, CXCL-1 and IL-
6, as well as SA-β-galactosidase staining (SA-β-gal).  Expression of CXCL-1 and IL-6 
increased in mice exposed to UV light when compared to non-exposed control mice.  
Additionally, the increase of these mRNAs only occurred in skin that was directly exposed to 
UV light (back) when compared to non-exposed skin (abdomen) of the same animals (Figure 
2.3, G and H).  Lastly, we observed a similar pattern of SA-β-gal staining.  Increased staining 
was observed in the skin from the back but not abdomen of the UV-treated mice 
(Supplemental Figure 2.4B).  These data suggest that chronic DNA damage from UV light 
accelerated the accumulation of senescent cells in vivo.    
 
2.4 Discussion  
 In this work, we demonstrate that serial imaging of p16
LUC 
mice can be used to study 
the senescence-promoting effects of environmental exposures such as arsenic, HFD, CS, and 
UVB. Through this approach, we found evidence that direct DNA damaging agents (i.e. CS 
and UV light) are potently gerontogenic with a lesser, but significant, effect of chronic 
arsenic exposure.  Moreover, using this in vivo reporter system, we identified the anatomic 
effects of these agents with regard to molecular aging.  For example, we showed the most 
marked effects of CS administered at modest dose by passive inhalation are on nasal epithelia 
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as opposed to lung parenchyma (Figure 2.2C) and that the most marked effects of UVB are 
on exposed rather than unexposed skin (Figure 2.3, E and F).   
 It is important to note two limitations of this system.  First, while luciferase imaging 
is considerably more sensitive than optical methods, the p16
LUC
 allele may be less useful for 
the detection of senescence induction in deeper organs or in rare cellular subtypes.  
Therefore, while we observed no effect of HFD on p16
INK4a
 induction at the total-body 
imaging level, it is possible HFD activates senescence in important cellular compartments 
(e.g. pancreatic beta-cells (Sone and Kagawa, 2005),  and vascular cells (Shi et al., 2007; 
Wang et al., 2009)), but not to a level detectable using this system.  Secondly, activation of 
p16
INK4a
 expression is only one component of molecular aging, which is a complex and 
multi-faceted process.  Therefore, the p16
LUC
 system does not detect cellular aging processes 
that occur independently of p16
INK4a
 expression; and likewise cannot be used to identify 
p16
INK4a
-independent gerontogens.  
 In summary, we have shown that the p16
LUC 
allele faithfully reports the in vivo 
activation of senescence markers in response to environmental toxicants, allowing for the 
determination of an agent’s gerontogenic effects using modest-sized cohorts of serially 
analyzed animals.  We believe this resource can supplement other rodent platforms used for 
toxicological assessments; in particular, providing an in vivo system to assess a compound’s 
age-promoting activity.  Finally, we believe this system will enhance our understanding of 
basic aging biology, by providing a tractable system for serial pharmacologic studies of aging 
in mice.   
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2.5 Figures 
 
Figure 2.1: High fat diet does not increase p16
INK4a
 expression, while arsenic moderately 
increases p16
INK4a
 expression in p16
LUC 
mice. 
(A)  Luciferase levels were measured periodically p16
LUC
 mice fed a high fat diet (green) or a 
normal diet  (purple)  as measured by total body luciferase radiance (TBLI). Luciferase levels 
were normalized to the mean luciferase levels of the entire cohort at day 0 and graphed as a 
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function of time.  The orange bar on x-axis indicates duration of exposure. Error bars indicate 
standard error of the mean.  P values were determined through linear regression analysis. (B) 
Representative images (52 weeks) of the study described in ‘A’ are shown. (C)  Luciferase 
levels were measured periodically p16
LUC
 mice exposed to 50 ppm arsenic (green) or 0 ppm 
(purple) as measured by TBLI (50 ppm, n=23, 0 ppm, n=14).  Results were recorded, 
analyzed, and displayed as in Figure 1A. (D)  Representative images (48 weeks) of the study 
described in ‘C’ are shown.   
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Figure 2.2: Cigarette smoke increases p16
INK4a
 expression in p16
LUC 
mice. 
 (A) Representative histological images of the upper sinus cavity (upper panel), airway 
bronchioles (middle panel), airway epithelium peg cells highlighted), and alveolar sacs 
(lower panel) from CS and AA mice after 54 weeks of exposure were stained with 
Hematoxylin & Eosin (H&E).  (B)  Luciferase levels were measured periodically in p16
LUC
 
mice exposed to cigarette smoke (green) or ambient air (purple) (CS, n=10; AA, n=10).  
Results were recorded, analyzed, and displayed as in Figure 1A. (C) Representative images 
(24 weeks) of the experiments described in ‘B’ are shown.  
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Figure 2.3: UVB light increases p16
INK4a
 expression in p16
LUC 
mice. 
 (A) Representative histopathological images of skin exposed (left) and not exposed (right) to 
UV light at sacrifice stained with H&E (top, middle) or phospho-H2AX (lower).  Both 
sections show dilated sebaceous glands and small, deranged hair papillae which is normal for 
these hairless mice.  (B) Representative dorsal images of mice (UV vs. non-exposed) after 6 
months of exposure.  (C)  Kaplan-Meier curve of mortality in the CS and AA cohorts 
(p<0.0001).  (D) Luciferase levels were measured periodically in p16
LUC
 mice exposed to 
350 J/m
2
 (green) or 0 J/m
2
 (purple) with emphasis on initial 20 weeks of exposure (inset) 
(350 J/m
2
, n=13; 350 J/m
2
, n=11).  Results were recorded, analyzed, and displayed as in 
Figure 1A. (E) Representative images (24 weeks) of the experiments described in ‘D’ are 
shown.   (F) Quantitative realtime PCR of p16
INK4a
 expression in the back and abdominal 
skin of UV treated and untreated mice at sacrifice.  *p<0.05, **p<0.01, ***p>0.005.   
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2.6 Supplemental Figures 
 
Supplemental Figure 2.1: Physiologically effective doses of high fat diet do not affect the 
survival rates of mice, and quantitative realtime PCR validates p16
INK4a
 expression as 
measured by TBLI. 
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 (A) The body mass of mice fed a high fat (HFD; 42% fat) or normal (ND; 4% fat) diet 
during the 52-week period of exposure (orange bar) (HFD, n=24; ND, n=15).  *p<0.05, 
**p<0.01. (B) Representative histopathological images of hemotoxylin and eosin (top) and 
osmium tetroxide (bottom) stained liver tissue from HFD mice ND mice at 84 weeks of 
exposure.  Hepatocytic lipid droplets are stained black and indicate severe steatosis in the 
high fat chow liver (right).  (C) Kaplan-Meier curve of mortality in the HFD and ND cohorts 
(p=0.8078) (D) Graph measuring individual weight vs luciferase induction (r
2
=0.024).  (E) 
Quantitative realtime PCR analysis of p16
INK4a
 expression in livers and spleens of each 
cohort at the after 84 weeks of exposure.  Orange bar on x-axis indicates duration of 
exposure. Error bars indicate standard error of the mean.    
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Supplemental Figure 2.2: Physiologically effective doses of arsenic do not affect the 
survival rates of mice, and quantitative realtime PCR validates p16
INK4a
 expression as 
measured by TBLI. 
 (A) Level of arsenic (ng/g) found by mass spectrometry in the liver of mice treated with 50 
ppm or 0 ppm arsenic for 48 weeks.  (B)   Representative hematoxylin and eosin stained 
sections of the pancreas 48 weeks following exposure to 0 ppm or 50 ppm arsenic.  (C) Area 
of individual islets in the pancreas of mice exposed to 0 ppm or 50 ppm arsenic. (D) Kaplan-
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Meier curve of mortality in the 50 ppm and 0 ppm cohorts (p=0.5164). (E) Quantitative 
realtime PCR of p16
INK4a
 in the liver and spleen in 50 ppm and 0 ppm mice after 52 weeks of 
exposure.  Orange bar on x-axis indicates duration of exposure. Error bars indicate standard 
error of the mean. ***p<0.0001   
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Supplemental Figure 3: Cigarette smoke does not affect the survival rates of mice, and 
quantitative realtime PCR validates p16
INK4a
 expression as measured by TBLI 
(A) Kaplan-Meier curve of mortality in the CS and AA cohorts (p=0. 4361). (B) Quantitative 
realtime PCR of p16
INK4a
 expression in the livers, spleens, lungs and lymph nodes of CS and 
AA mice after 52 weeks of exposure.  Orange bar on x-axis indicates duration of exposure. 
Error bars indicate standard error of the mean. ***p<0.0001   
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Supplemental Figure 2.4: UV light leads to a senescent phenotype in skin. 
 (A) Quantitative analysis of H2AX staining in the back skin of UV exposed and non-
exposed cohorts. (B) SA β-galactosidase staining of skin from the backs and abdomens of 
UV exposed and unexposed mice. Unexposed back skin from young mice (8 weeks old) was 
used to determine background staining (bottom).  **p<0.01   
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 CHAPTER 3: REGULATION OF TRANSIENT INDUCTION OF p16
INK4a  
 
3.1  Introduction 
 The cell cycle inhibitor, p16
INK4a
, has been well documented as a tumor suppressor 
protein that once transcriptionally activated, will lead to cellular senescence, a permanent 
state of growth arrest.  Additionally, prior work has shown that there is accumulation of 
senescent cells in aging tissue (Krishnamurthy et al., 2004; Liu et al., 2009; Serrano et al., 
1997).  However, there has been limited work to describe the transient induction of p16
INK4a
 
expression in vitro and even less in vivo.  A few groups have described genetic manipulation 
of p16
INK4a
 using inducible constructs to cause temporary increase in expression leading to a 
growth pause, instead of senescence in vitro (Frost et al., 1999; Rossi et al., 1998; Stone et 
al., 1996).  Using cell lines, one group showed that p16
INK4a
 expression for 1 day arrested the 
cells in G1.  However, upon return to p16
INK4a 
baseline levels, the cells resume growth after 
3-5 days.  Interestingly, if p16
INK4a
 was induced for 6 days, the cells never again proliferated 
and developed a senescent phenotype (Dai and Enders, 2000), suggesting a temporal trigger 
to transition the cell from a G1 pause to permanent growth arrest.  While in vitro work is 
helpful, the questions understanding transient induction of p16
INK4a
 in vivo remain 
unanswered. 
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 Research has shown that there is an induction of p16
INK4a
 at the site of wound closure 
in both cells and humans.  More specifically, others have shown that induction of 
matricellular protein, CCN1, will cause p16
INK4a
-dependent fibroblast senescence at site of 
wound repair and inhibit fibrosis during tissue repair (Jun and Lau, 2010a, b).  Additionally, 
p16
INK4a
 has been associated with keratinocyte migration during wound repair.  Laminin5, a 
basement membrane protein, is co-expressed with p16
INK4a
 along the edges of a wound in 
culture and in vivo (Natarajan et al., 2005; Natarajan et al., 2003).  Additionally, during 
migration, p16
INK4a
 is induced to lessen the potential for invasion and transformation 
(Natarajan et al., 2006).  Chronic wound healing has been shown to cause squamous cell 
carcinoma with loss of known senescence markers including p16
INK4a
 and MMP-19 (Impola 
et al., 2005; Telgenhoff and Shroot, 2005). 
 UV burn repair has a very similar physiology to wound regeneration.  Both insults 
lead to a re-epithelialization, inflammatory repsonse, and formation of granulation tissue 
(Singer and Clark, 1999).  Exposure to high doses of UV light has also been shown to cause 
induction of p16
INK4a
 leading to cell cycle arrest in Hela cells (Wang et al., 1996).  
Additionally, many groups have shown that chronological aging, which has a strong 
correlation with p16
INK4a 
expression in both mice and humans (Krishnamurthy et al., 2004; 
Liu et al., 2009; Nelson et al., 2012; Zindy et al., 1997), will lead to a slower healing 
response, including delayed re-epithelialization, delayed angiogenesis, and decreased 
secretion of growth factors, after exposure to high doses UV light (Gilchrest et al., 1982; 
Gosain and DiPietro, 2004).  Others have also shown that the components of Retinoblastoma 
(Rb) pathway, which includes p16
INK4a
, are important targets of UV-induced mutagenesis 
during melanoma development (Kannan et al., 2003).  Given these intimate links between 
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wound healing, UV light and p16
INK4a
 expression, we sought to determine the magnitude and 
duration of transient p16
INK4a
 activation upon insult, measured through the use of a recently 
described reporter allele in vivo.   
 During tissue repair, macrophages have been shown to infiltrate the wound site to 
clear remaining pathogens and cellular debris by day 4 (DiPietro, 1995).  Once activated, 
macrophages will signal neighboring cells for excretion of growth factors and cytokines to 
help regenerate the damaged tissue (Martin, 1997).  Research has also shown age-related 
differences in MCP-1 production, a monocyte chemoattractant protein, to the wound 
following burn injury in vivo. More specifically, the levels of MCP-1 in aged burned mice 
were less than half the levels of young burned mice 1 day after burn, suggesting an 
association between p16
INK4a
 expression and monocyte chemoattractant production (Shallo et 
al., 2003).  Lastly, the CDKN2A locus, which encodes p16
INK4a
 and ARF transcripts, is 
associated with macrophage proliferation and recruitment during atherosclerotic (an age-
related disease) development in humans (Kuo et al., 2011).  Moreover, p16
−/−
 bone marrow-
derived macrophages (BMDMs) exhibit a decreased response to classically polarizing IFNγ 
and LPS, and an increased sensitivity to alternative polarization by IL-4, suggesting a 
potential role for p16
INK4a
 as a modulator for macrophage activation and polarization 
(Cudejko et al., 2011).  Due to the strong association between p16
INK4a
 and macrophage 
recruitment, we examined the role of macrophages during transient induction of p16
INK4a
 
through in vivo analysis. 
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3.2 Materials and Methods 
 Experiments were performed under protocols approved by the institutional care and 
use committee (IACUC) of the University of North Carolina. Hairless SKH1-E p16
LUC/+
 
mice were used for all experiments (Burd et al., 2013).  Genotyping was performed as 
previously described (Burd et al., 2013).  For histologic analysis, tissues were fixed with 10% 
formalin overnight, and then transferred to 70% ethanol for paraffin blocking and staining.  
All slides were generated and stained with Hematoxylin and Eosin at the UNC 
Histopathology Core.  Statistical significance was determined using a student’s t-test for all 
comparisons.  All gross anatomy photos were taking with 6.0 megapixel Canon SD630. 
3.2.1 Transient Inductions 
Wound Generation:  At 8-10 weeks of age, mouse p16
LUC/+
 (SKH1-E background) or p16
+/+
 
and p16
-/-
 (C57/B6 background) were anesthetized with inhaled 2% isofluorane.  Once 
anesthetized and after cleansing the 1 sq cm area with iodine, a sterile 3 mm punch was used 
to create one full-thickness wound on the dorsal side of each mouse, just below the shoulder 
blades. SKH1-E mice were imaged for luciferase following a specific schedule (Figure 1A) 
until the wound healed. C57/B6 mice wounds were measured weekly using a caliper until 
completely healed. 
UV light: A UVB lamp from UVP was used for these studies, with an emission spectrum of 
290-350 nm light, and with a peak emission at 312 nm.  At 8-10 weeks of age, mice were 
exposed to 2000 J/m
3
 of UVB once. UV exposure was given after initial baseline imaging.  
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Mice were imaged for luciferase following a specific schedule (Figure 2A) until wound 
healed. 
3.2.2 Drug Treatments 
Dexamethasone: Mice were given a daily intraperitoneal injection (I.P.) of dexamethasone 
(Sigma D4902) at dose of 7 mg/kg diluted in Phosphate Buffered Solution (PBS) for the first 
16 days after wounding (Figure 3A). 
IKK-β Inhibitor: Mice were given an intraperitoneal injection (I.P.) of compound A (Dr. Al 
Baldwin’s drug) at dose of 10 mg/kg dose diluted in dimethylsulfoxide (DMSO) starting 6 
days before wounding and ending 16 after wounding (Figure 3C). 
Clodrosome: Mice were given a daily intravenous injection (I.V.) of liposomal clodronate 
(Encapsula NanoSciences SKU #STLMDK) at dose of 100 uL/per mouse for the three days 
before the wounding (Figure 4A). 
3.2.3 Flow Cytometry 
Bone marrow, splenic, and peripheral white blood cells were isolated as previously described 
(Kiel et al., 2005).  Once the cells were isolated, cells were stained with B220-violet (B cell 
marker), Gr1-APC-Cy7 (granulocyte marker), F4/80-FITC (macrophage marker), and Mac1-
PE-Cy7 (monocyte marker).  Flow cytometry analysis was completing using Beckman-
Coulter (Dako) CyAn ADP machine with the strategy shown in Figure 4B. 
Figure 4B is a schematic that describes the gating strategy for F4/80+Mac1+ population 
identification.  First, all cells with proper size and granularity (FS lin, SS lin) were gated for 
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B220.  Then, all B220- cells where gated for Gr1.  Lastly, all Gr-1- cells were gated for Mac1 
and F4/80.  All Mac1+F4/80+ cells were used for analysis. 
3.2.4 In vivo Luminescence Imaging 
Luciferase Imaging: To serially monitor luciferase induction, mice were imaged as 
previously described (Burd et al., 2013) using a Zenogen IVIS LUMINA Imaging System.  
Imaging was completed under anesthesia, immediately after D-luciferin injection (10 mg/ml 
in sterile PBS). Sequential imaging was used to determine optimal luminescence.  A 
sequence of 2 min, 2 min, 2 min, 2 min, 30 sec, and 1 min were used.  The 4
th
 two minute 
image (8 minutes after initial injection) was used for all reported imaging measurements.  For 
all exposures, images were taken of the dorsal side of the mouse.  Living Image 3.1 Software 
(Caliper Life Sciences) was used to analyze the images at the same image exposure time 
point (8 min) over the experiment.  Representative images are shown with wounded and non-
wounded animals for each cohort, as well as appropriate imaging scales to account for 
imaging settings.  For data analyses, the raw average radiance values 
(photon/sec/cm
2
/steradian) from the original images were used.  A wide angle lens (FOV-24) 
was used to capture images of 3 or more mice. 
Data Analysis: For each experiment, mice were imaged following a specific schedule (Day 0, 
2, 4, 7, 10, 16).  Each mouse was circled to measure average radiance values (p/s/cm
2
/sr) 
over the region of interest.  The area for each mouse was held constant for each experiment.  
A blank area on the image was also circled to allow for subtraction of background noise.  To 
omit background noise from each individual mouse image, the background circle on a non-
exposed area of the mouse was subtracted from the exposed area circle.  To graph the 
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luciferase induction over time, all murine luciferase signals in a specific cohort were 
averaged at time zero and normalized to a value of one.  All subsequent mouse images were 
then normalized relative to the average time zero luminescence. 
 
3.3 Results 
 The p16-LUC allele includes firefly luciferase ‘knocked-in’ to exon 1α of the murine 
Cdkn2a locus, placing luciferase under the control of the endogenous p16
INK4a
 promoter as 
well as cis-regulatory elements, which are known to extend for several hundred kilobases 
around the locus (Burd et al., 2010; Burd et al., 2013; Visel et al., 2010).  Expression of 
p16
INK4a
 can potentially increase to more than 300-fold on a per cell basis making p16
LUC
 a 
valuable tool for in vivo imaging of transient induction of p16
INK4a 
(Burd et al., 2013; 
Krishnamurthy et al., 2004).  To assess the kinetics and duration of p16
INK4a
 expression after 
dermal insult, we performed serial analysis of p16
LUC
 cohorts.  Hairless SKH1-E mice were 
used for all studies to further heighten in vivo luciferase signal. 
3.3.1 Wound Healing Model 
 Research has shown that p16
INK4a
 is induced at the edge of a wound during healing in 
vitro (Natarajan et al., 2003).  Others have also shown that chronic wounding will lead to 
p16
INK4a
-associated skin cancers (Telgenhoff and Shroot, 2005).  Using the previously 
characterized p16
LUC
 allele, we sought to determine the duration of p16
INK4a
 during wound 
regeneration.  SKHI-E mice were imaged for a baseline and then immediately wounded on 
the dorsal side between the shoulder blades.  Mice were serially imaged for up to a month 
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until the wound was healed (Figure 1A).  Through observation and histological analysis, 
wounds healed as previously recorded (Figure 1B) (Bradshaw et al., 2002) .  There was clear 
induction of p16
INK4a
 at the site of the wound by 2 days after wound generation, with peak 
induction by 4 days (Figure 1, D and E).  p16
INK4a
 expression returned to baseline by 16 days, 
when the wound had healed (Figure 1D).  To determine if p16
INK4a
 played a role in wound 
closure rate, C57/B6 mice at varying ages (5 months and 10 months) with and without p16, 
were wounded and closure was measured.  Older mice (10 months old), have an initially 
slower wound closure than the younger mice (5 months old), regardless of p16
INK4a
 status, 
suggesting p16
INKa
-independent age-related factors, including other age-dependent cell cycle 
inhibitors (e.i. ARF) play a role in wound regeneration (Figure 1C). 
3.3.2 UV Burn Model 
 Not only does UV burn healing have a similar pathological phenotype as cutaneous 
wound healing, UV burns have also been associated with p16
INK4a
 induction.  For example, 
UV light has been shown to cause induction of p16
INK4a
 in cells (Cadet et al., 2005).  
Additionally, prior work has shown that UV light causes mutagenesis in the Rb pathway, 
including p16
INK4a
, leading to melanoma (Kannan et al., 2003).  To understand how UV 
exposure affects transient p16
INK4a
 induction, SKH1-E mice were exposed to either 1000 J/m
2
 
or 2000 J/m
2
 then serially imaged for 30 days (Figure 2A).  Whole body examination 
demonstrated redness and edema at site of UV exposure validating an effective dose (Figure 
2B).  Through imaging analysis, UV light led to dorsal specific induction of p16
INK4a
 starting 
2 days after exposure with maximal expression at 4 days with levels 1.75 times higher than 
baseline (Figure 2, C and D).  p16
LUC
 signal is seen at the site of UV exposure, indicating 
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anatomic specific expression (Figure 2D).  These results suggest that UV light leads to a 
rapid, transient expression of p16
INK4a
. 
3.3.3 Pharmacological Modulation of p16
INK4a
 transient expression 
 Pharmacological inhibitors were employed to determine the mechanism of p16
INK4a
 
transient induction after UV exposure.  Others have shown that inflammation can lead to the 
induction of p16
INK4a
 (Freund et al., 2010).  Moreover, glucocorticoids, are shown to suppress 
components of the senescence associated secretory phenotype, including IL-6, IL-8, GM-
CSF, and MCP-2 expression (Laberge et al., 2012).  In vivo, glucocorticoid receptors have 
been correlated with p16
INK4a
 levels in tumors, suggesting a potential relationship with 
dexamethasone, a glucocorticoid, and p16
INK4a
 expression (Theocharis et al., 2003).  
However, how dexamethasone affects p16
INK4a
 expression after cellular insult is unknown.  
To address this question, SKH1-E mice were given a daily I.P. injection of dexamethasone 
every day, starting from the day of UV burn.  The mice were then serially imaged for 30 days 
(Figure 3A).  Luciferase signal was recorded and dexamethasone-treated and non-treated 
mice were compared.  Interestingly, dexamethasone treatment hindered induction of p16
INK4a
 
to almost baseline levels, suggesting an inflammatory response after UV exposure leading to 
the transient induction of p16
INK4a 
(Figure 3B).   
 Next, we examined the NfκB pathway to further understand the relationship between 
p16
INK4a
 and the inflammatory response during UV burn healing. Prior work has shown that 
the NfκB pathway plays an important role in the inflammatory response system (Pahl, 1999).  
Additionally, research has shown that NfkB has a direct relationship with a senescent 
phenotype in both mice and cells (Rovillain et al., 2011; Tilstra et al., 2012).    Moreover, 
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NfκB in conjunction with p38, a known upstream inducer of p16INK4a, regulate the 
senescence associated secretory phenotype (Freund et al., 2011).  To understand the 
relationship between NfκB and p16INK4a pathways, we treated UV exposed mice with 
compound A, an IKK-β inhibitor.  IKK-β is part of the IKK complex, which is the initial step 
in the NfκB cascade.  By inhibiting IKK complex’s ability to phosphorylate the IkB complex, 
the NfκB pathway is hindered.  Our results show mice treated with compound A, every other 
day starting six days before UV exposure (Figure 3C) exhibited lower p16
INK4a
 induction 
after UV burn, further strengthening the hypothesis that inflammatory response after UV 
exposure leads to the induction of p16
INK4a 
(Figure 3D). 
 Macrophage recruitment during an inflammatory response occurs four days after 
insult at the peak of p16
INK4a
 induction after UV burn (Figure 2D, (DiPietro, 1995)).  Others 
have shown the p16
INK4a
 is responsible for the activation of tissue macrophage phenotypes 
(Cudejko et al., 2011; Fuentes et al., 2011), suggesting a role for p16
INK4a
 during macrophage 
recruitment.  Additionally, Cdkn2A, the locus that encodes p16
INK4a
, has been shown to 
regulate macrophage proliferation (Kuo et al., 2011).  To determine if p16
INK4a
 is induced in 
macrophages during recruitment to the wound, mice were treated with daily I.P. injections of 
clodrosome, a macrophage depletion compound, starting three days before UV exposure 
(Figure 4A).  Mice were UV burned on day 0, then serially imaged for 30 days.  To confirm 
sufficient depletion, peripheral blood, spleen, and bone marrow were harvested from a cohort 
of mice on day 4.  These cells were stained for specific blood markers, and macrophages 
were measured using flow cytometry (Figure 4B).  Cells that were stained Mac1+F4/80+, 
known macrophage markers, were then compared between the clodrosome treated and non-
treated cohorts.  As expected, there was a significant decrease in splenic macrophages, a 
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modest decrease in peripheral blood macrophages, with no change in bone marrow derived 
macrophages, validating the data generated from this experiment (Figure 4C).  Our imaging 
results demonstrate the treatment with clodrosome lessened the p16
INK4a
 inducing effects of 
UV burn, suggesting that macrophages play a role in the transient induction of p16
INK4a
 
(Figure 4D). 
 
3.4 Discussion 
 In this work, we demonstrate through the use of the p16-LUC allele, we are able to 
transiently induce p16
INK4a
 through wounding and UV burns.  Moreover, we have effectively 
modulated expression of p16
INK4a
 after exposure of UV burns by altering the inflammatory 
response through treatments with dexamethasone, a glucocorticoid, compound A, an IKK-β 
inhibitor of the NFκB pathway, and clodrosome, a macrophage inhibitor.  These data suggest 
the transient induction of p16
INK4a
 is due to the inflammatory response, potentially through 
recruitment of macrophages to wound site after a cellular insult, such as a UV burn (Figure 
5).   
 To better understand the relationship between p16
INK4a
 and macrophage infiltration, 
we plan on completing a series of transplant experiments.  Currently, we have clearly 
demonstrated that p16
INK4a
 is predominantly expressed at the site of insult; however, the cell 
type is unknown.  To confirm the cell type, we plan on transplanting the bone marrow of 
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mice that have wildtype p16
INK4a
 with bone marrow from mice that have heterozygous for the 
p16
LUC
 allele.  If there is induction at the site of the insult (luciferase glow at the burn site), 
p16
INK4a
 expression is from the circulating white blood cells.  If induction is seen, the white 
blood cells with be sorted into specific populations using the protocol described, and 
adoptively transferred into wildtype p16
INK4a
 mice, to determine cell specific induction.  To 
strengthen the theory that macrophage infiltration leads to a stronger p16
INK4a
 expression, we 
will inject mice with KRAS transformed cells that have extras copies of colony stimulating 
factor 1 (CSF-1), a macrophage recruitment signal, and measure tumor growth and luciferase 
signal.  If our hypothesis is correct, then we should see higher levels or faster induction of 
p16
INK4a
 in mice that have the extra CSF-1 when compared to the empty vector controls.   
 In summary, we have shown that both wounding and UV burn lead to a transient 
induction of p16
INK4a 
with maximum expression at day 4.  We have also shown using the UV 
burn model that inflammatory responses, including macrophage infiltration and induction of 
the NFκB pathways, affect p16INK4a transient expression.  While there are many questions 
that remain unanswered, these experiments develop a platform to better understand p16
INK4a 
transient expression in vivo. 
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3.5 Figures 
 
Figure 3.1: Wound healing leads to an induction of p16
INK4a
 expression in mice 
(A) Model describing the imaging protocol for wounded mice.  (B) Gross and histological 
(stained with hematoxylin and eosin) images of a wound healing up to day 16. (C) Size of 
wounds in p16-/- and p16+/+ mice graphed as a function of time. Error bars indicate standard 
error of the mean.  (D)  Luciferase levels were measured periodically of p16
LUC
 wounded 
mice as measured by TBLI (wound, n=13, no wound, n=9).  Luciferase levels were 
normalized to the mean luciferase levels of the entire cohort at day 0 and graphed as a 
function of time.  (E) Representative images (day 4) of the study described in ‘D’ are shown.  
Error bars indicate standard error of the mean. P values were determined through student’s t-
test analysis.  *p<0.05  
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Figure 3.2: UV burn leads to an induction of p16
INK4a
 expression in mice 
 (A) Model describing the imaging protocol for burned mice.  (B) Gross images of exposed 
and non-exposed mice at day 7. (C)  Luciferase levels were measured periodically of p16
LUC
 
mice wound as measured by TBLI (0J/m
2
, n=4, 1000 J/m
2
, n=5, 2000J/m
2
, n=9).  Results 
were recorded, analyzed, and displayed as in Figure 1D. (D) Representative images (day 7) 
of the study described in ‘C” are shown.  Error bars indicate standard error of the mean. P 
values were determined through student’s t-test analysis comparing 2000J/m2 vs. 0J/m2. 
**p<0.01 
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Figure 3.3: Glucocorticosteriod and NfκB inhibitor interfere with the transient 
induction of p16
INK4a
 expression in mice after UV burn 
 (A) Model describing the imaging and dosing protocol for dexamethasone-treated, burned 
mice.  (B)  Luciferase levels were measured periodically of p16
LUC
 mice wound as measured 
by TBLI (0J/m
2
, n=4, 2000J/m
2
, n=9, Dexamethasone+2000J/m
2
, n=4).  Results were 
recorded, analyzed, and displayed as described in Figure 1D. (C) Model describing the 
imaging and dosing protocol for the IKK-β inhibitor compound A-treated, burned mice.  (D)  
Luciferase levels were measured periodically of p16
LUC
 mice wound as measured by TBLI 
(0J/m
2
, n=4, 2000J/m
2
, n=9, compoundA+2000J/m
2
, n=3).  Results were recorded, analyzed, 
and displayed as described in Figure 1D. Error bars indicate standard error of the mean. P 
values were determined through student’s t-test analysis comparing 2000J/m2 vs. 
tmt+2000J/m
2
. *p<0.05, ***p<0.001 
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Figure 3.4: Macrophage depletion interferes with the transient induction of p16
INK4a
 
expression in mice after UV burn 
 (A) Model describing the imaging and dosing protocol for clodrosome (liposomal 
clodronate) treated, burned mice.  (B) Flow cytometry strategy to determine the macrophage 
population (Mac1+F4/80+). See methods for further description. (C) Graph depicting the 
levels of Mac1+F4/80+ cells of clodrosome-treated vs. non-treated in the peripheral blood, 
spleen, bone marrow (BM) on day 4 (bolded arrow in Figure 4A). (D) Luciferase levels were 
measured periodically of p16
LUC
 mice wound as measured by TBLI (0 J/m
2
, n=4, 2000 J/m
2
, 
n=9, clodrosome+2000 J/m
2
, n=3).  Results were recorded, analyzed, and displayed as 
described in Figure 1D. Error bars indicate standard error of the mean. P values were 
determined through student’s t-test analysis comparing 2000J/m2 vs. tmt+2000J/m2. *p<0.05, 
**p<0.01  
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Figure 3.5: A working model of p16
INK4a
 induction after wound generation or UV burn. 
The wound healing process (after puncture or burn) causes an inflammatory response with a 
macrophage infiltration by day 4.  The inflammation, including the infiltration of 
macrophages at wound site leads to an induction of p16
INK4a
 expression.   
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CHAPTER 4: OVERALL CONCLUSIONS AND SIGNIFICANCE 
 
4.1 Principal Conclusions 
 There have been great strides in developing better assays to understand the molecular 
underpinnings of carcinogens, but the field of gerontogens is not as established.  My work 
describes a way to evaluate the severity of a gerontogen in vivo using a novel mouse model 
which has allowed us to systemically evaluate four different exposures in mice (Chapter 2).  
Contrary to the known literature, my work also shows how p16
INK4a
 does not always 
accumulate in an organism, and might have a niche of transient induction after a wounding 
event, such as a UV burn (Chapter 3).  In summary, my work provides an innovative method 
for measuring molecular age after chronic exposure to gerontogens and begins to clarify a 
novel role for p16
INK4a
 transient expression in vivo. 
 
4.2 p16
INK4a
 -Luciferase Allele 
 Our lab has generated a luciferase reporter allele (p16
LUC
) that measures p16
INK4a
 
expression in cancer and aging.  Our lab demonstrated that p16
INK4a
 is induced in the stromal 
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region of a tumor before tumor palpation in vivo using the p16
LUC
 allele (Burd et al., 2013).  
Additionally, we show that the p16
LUC
 allele will detect tumorigenesis in many different 
tumor types including breast and melanoma.  Chapter 2 defines multiple gerontogens and 
verifies the allele’s ability to measure p16INK4a-associated aging in vivo.  In this paper, we 
also validate the expression of p16
INK4a
 after chronic exposure, and correlated the expression 
with a senescent phenotype through SA-β gal staining and mRNA expression of SA factors 
including Il-6 and CXCL1.  Currently, we are completing experiments to understand the 
mechanisms of transient induction of p16
INK4a
 using the p16
LUC
 wound healing model 
through pharmacological modulation of the p16
INK4a
 expression after a UV burn.  The p16
LUC
 
reporter allele has made it easier to understand the relationship between p16
INK4a
-associated 
cancer and aging. 
 Not only has the p16
LUC
 allele made advancements from a scientific standpoint, this 
allele is a novel in vivo model that can serially measure a specific protein in the same organ 
over time.  Historically, aging in vivo studies are very long and expensive since there are 
tremendous costs for mice, as well as cage costs for having the mice aging for months and 
possibly years.  Additionally, there are incredible costs for the time invested, and proper 
storage of all tissues after the conclusion of the experiment.  By using a mouse model that 
can measure the protein of interest (p16
INK4a
) in real time, it decreases the costs exponentially 
and lessens the time commitment significantly. 
 While the p16
LUC
 allele, as with other luminescent reporter alleles, has furthered 
scientific knowledge, there are few minor, but important weaknesses that should be 
addressed.  Firstly, there is some individual variation.  An individual mouse imaged over a 
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period of time will show a slow, but steady, induction of luciferase signal correlative with 
endogenous p16
INK4a
 expression.  However, this signal will not be linear, with slight spikes 
and drops throughout the life of the mouse.  Additionally, measuring a set of mice at the 
same time point (e.g. same age) will also yield some variability, which is characteristic of 
p16
INK4a
 expression in human PBTLs (Liu et al., 2009).  To fix these issues, internal controls 
were used per mouse to correct for any background induction (transient exposures), and 
higher cohort numbers (15+) were used if variability was expected to be higher than normal 
(e.g. chronic exposures).  Secondly, since the luciferase allele required an I.P. injection of 
luciferin before each image set, technical variation of injection placement, amount of 
luciferin injected, and time to image taken can also confound results.  To address these 
variations, multiple sets of mice were taken over many months to make sure it was not a dose 
dependent response of the luciferin.  Each image taken included mice from various cohorts if 
space permitted.  To stabilize the time to image variation, experiments were completed to 
determine steady state of luminescence after injection, which was 8 minutes.  Additionally, 
we determined that 48 hours were needed before mice could be re-imaged with maximal 
luminescence potential.  Mice were also weighed before each luciferin injection to confirm 
the proper luciferin serum concentrations.  Though both minor, these shortcomings were 
taken into consideration during the course of the studies and addressed to maintain accurate, 
reliable data. 
 One major limitation of the p16
LUC
 allele is the lack of cellular specifically, making it 
difficult to detect p16
INK4a
 induction in deeper organs or in rare cellular subtypes.  For 
example, the reason for no p16
INK4a
 expression differences in the HFD vs. ND (Chapter 2) 
might be due to  the significant age-related changes are in a small subset of cells, such as the 
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pancreatic β cells, or in a deep organ, such as the aorta or pancreas, making imaging 
detection difficult.  While some validation of luciferase signal correlating with p16
INK4a
 
mRNA expression was completed in these studies, to completely address this problem, 
another allele will need to be generated.  A new allele will need to encompass the faithful 
induction of p16
INK4a
, while allowing a level of detection in a single cell.  Currently, our lab 
is generating a second allele that will have a red florescence protein (tdTomato) in place of 
p16
INK4a
 exon 1α, leaving exons 2 and 3 intact, identical to the p16LUC allele (Figure 4.1).  
tdTomato florescence protein was chosen due to its strong signal and limited similarity to 
auto-florescence during flow cytometry analysis.  Ideally, these mice will have the potential 
to be imaged in real time as well as run flow cytometry analysis on cellular subtypes in order 
to address those cellular p16
INK4a
-related questions.  The p16
INK4a
-tdTomato (p16
TOM
) allele 
will also help us determine whether p16
INK4a
 induction is stochastic or gradual among a 
cellular population.  Currently, we don’t know if a 50% increase in p16INK4a expression 
means 50% of the cells are expressing 100% of p16
INK4a
 expression or if all cells are 
expressing 50% of the p16
INK4a
 expression, and this allele can elucidate those differences.  
Even though it is thought that p16
INK4a
 is only regulated at the transcriptional level, there still 
might be unanswered questions at the translational level.  Both of these alleles will show 
effects on p16
INK4a
 expression at the transcriptional level, leaving the protein regulation in 
question.   
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4.3 Theory of gerontogens 
 George Martin developed a new philosophy about exposures that lead to an aging 
phenotype and coined the term gerontogens (Martin, 1987).  Gerontogens are defined as an 
exposure that leads to an advanced aging phenotype.  While this opened the door to a new 
thought process about aging toxicology, there were a few questions that were left 
unanswered; What is an “aging phenotype”? How do you measure aging? Can a gerontogen 
also be a carcinogen? 
 An “aging phenotype” implies an array of different theories.  Some have described 
molecular aging as the “lack of proliferative potential” (Kim and Sharpless, 2006), while 
others considered aging as a diminished lifespan, and often a frailty phenotype (Bryson and 
Siddiqui, 1969; McMillan and Hubbard, 2012).  Aging phenotypes can also include clinical 
outcomes of the elderly including neuro-degeneration, atherosclerosis, cancer, diabetes, 
immune suppression, glaucoma, endometriosis, and coronary artery disease (CAD) (Jeck et 
al., 2012).  Interestingly, the molecular mechanisms that lead to these age-related pathologies 
are vastly different and at times completely opposite.  For example, cancer and 
atherosclerosis are considered highly proliferating disease, while diabetes and neuro-
degeneration pathologies are due to lack of regenerating populations of specific cells.  To be 
able to call a toxicant a gerontogen, the aging phenotype must be defined.  For the purposes 
of my studies, I defined gerontogens as toxicants that lead to a lack of cellular regeneration 
as well as have associations with age-related diseases.  For my study, I chose high fat diet 
(increased susceptibility to diabetes), arsenic (increase susceptibility to diabetes), ultraviolet 
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light (photo aging, e.g. slower wound repair, lack of elasticity), and cigarette smoke (a wide-
array of pathologies, including immune suppression and CAD) as my gerontogen panel. 
 After gerontogens are defined, there are many ways to measure the aging phenotype, 
which includes whole organism measurements such as decrease in lifespan and onset of age-
related pathologies as described above.  As described in the Chapter 1, there are also many 
different molecular markers to measure the aging phenotype.  To utilize our novel p16
LUC
 
system, I measured p16
INK4a
 mRNA expression levels as my molecular marker after exposure 
to the gerontogens of choice. I also tested of validity of p16
INK4a
 expression as an aging 
marker, and senescence activator, by evaluating CXCL1 and IL-6 mRNA levels (SASP 
factors) as well as SA β-gal stain (senescence marker).  The evaluation of p16INK4a expression 
was successful in measuring aging in certain gerontogens, including UV light and cigarette 
smoke, but was less successful in measuring the aging phenotype in others, such as arsenic 
and high fat diet (Chapter 2).  While p16
INK4a
 expression showed a modest, but significant 
change in arsenic exposed mice, the lack of pancreatic islets suggests that arsenic is a 
stronger gerontogen than we describe.  Likewise, even though there were no differences 
between the mice fed high fat and normal fat diets, it doesn’t mean high fat diets can’t be 
considered a gerontogen.  As discussed earlier, this can be due to changes in p16
INK4a
 
expression in a small subset of cells or deeper organs not detectable by the luciferase system.  
Additionally, our system is not set up to detect age-related changes other that lack of 
regeneration, or more specifically changes in p16
INK4a
 expression.  Both arsenic and high fat 
diet might have age-related phenotypes not associated with p16
INK4a
 expression.   In fact, 
both arsenic and high fat have been associated with highly proliferative pathologies, 
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including atherosclerosis and cancer (Giovannucci and Goldin, 1997; Keys, 1952; Mosby et 
al., 2012; Nishina et al., 1990; Smith et al., 1992).  
 Future experiments for this project would take two different directions.  Firstly, I 
would better characterize the “gerontogeness” of the two more dynamic p16INK4a expressing 
gerontogens.  I would solidify that exposure to either UV light or cigarette smoke would lead 
to induction of p16
INK4a
, which leads to a lack of proliferation.  For this, cell culture analysis 
would be employed on organs with the highest levels of p16
INK4a
, including 3T9 cellular 
passaging assays.  Secondly, I would also better define the type of “gerontogeness” the other 
two less p16
INK4a
 associated gerontogens.  For this, I would test other markers of aging, 
including telomere length and oncogene activation.  I would also more closely analyze 
potential specific organs that are hotspots for age-related pathologies.  For example, in HFD 
fed mice, I would look at p16
INK4a
 expression in the aorta and pancreatic β cells.  In the 
arsenic exposed mice, I would analyze the pancreatic β cells for p16INK4a expression as well 
as measure characteristics of skin aging including elasticity and wound healing.  In summary, 
detecting changes in p16
INK4a
 expression is not the only way to measure aging in vivo. 
 Finally, there is some overlap between “carcinogens” and “gerontogens”, including 
the relationship between both classes and p16
INK4a
 expression.  As addressed briefly in 
Chapter 1, cancer is considered an age-related pathology along with other highly proliferative 
diseases, including atherosclerosis.  They occur more frequently at the later stages of life, but 
the opposite of the “aging” mechanism, or lack of regenerative potential.  p16INK4a has been 
shown to be involved with many cancers including melanomas and breast  cancer (Herman et 
al., 1995), while also known to lead to replicative decline in many tissues, such as pancreatic 
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β cells and neural progenitors (Krishnamurthy et al., 2006; Molofsky et al., 2006).  
Mechanistically, p16
INK4a
 has been shown to be induced after oncogenic stimuli, leading to 
cell cycle arrest and ultimately senescence, giving this protein tumor suppressor status 
(Bartkova et al., 2006; Serrano et al., 1997).  However, many tumors have p16
INK4a
 silenced, 
through methylation of the promoter for example, allowing the cell to bypass the tumor 
suppression and hyper proliferate leading to cancer (Herman et al., 1995).  DNA damage, 
either direct or indirect, has also been shown to induce p16
INK4a
 as described in Chapter 2.  
Chronic DNA damage can also lead to suppression of the CDN2A locus, allowing the 
transition into a tumorigenic state (e.g. UV light-induced melanoma) (Kannan et al., 2003).  
The commonality with the different relationships of p16
INK4a
 induction and cancer is that 
somehow the original insult, whether it is oncogenic stimuli or DNA damaging agent, causes 
an induction of p16
INK4a
 to senesce the cell before transition into a malignant state.  The 
mechanism as to how the cells moves from extremely high levels of p16
INK4a
 to a silenced 
CDKN2A
 
locus, bypassed senescent state, and subsequently tumorigenesis is still unclear.  
Additionally, our group has shown the p16
INK4a
 is produced in the stromal cells around a 
tumor, suggesting some signal for normal cells to stop proliferating.  As my recent work 
proposes (Chapter 3), macrophage infiltration with high levels of p16
INK4a
 expression may 
explain the influx of p16
INK4a
 localized around the tumor or wound. 
 
4.4 p16
INK4a
 regulation in vivo 
 As described above, p16
INK4a
 is a tumor suppressor that regulates the G1 to S phase 
transition of the cell cycle through the RB pathway (Kim and Sharpless, 2006).  While it is 
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known that p16
INK4a
 expression leads to a permanent growth arrest, it is still unclear how the 
cell switches from a paused state in the cell cycle to a senescent state.  A tremendous effort 
has been made to determine the regulation of p16
INK4a
 expression.  Prior work has shown that 
many transcription factors, including the polycomb group proteins, contribute to p16
INK4a
 
modulation (Bracken et al., 2007).  The immediate upstream transcription factors have been 
discovered, however, relationship between environmental exposure and modulation of 
transcription factors remains unclear.  Moreover, very little work has been completed to 
understand the transient induction in vivo. 
 Our newest experiments have shown that p16
INK4a
 is transiently induced four days 
after a wound is generated (Chapter 3).  The transient induction can be caused by one or a 
combination of the following hypotheses:  1) transcription factors that regulate p16
INK4a
 
expression to turn on momentarily, 2) there is an influx of a specific cell type that has high 
level of p16
INK4a
 to the wound site, suggesting a concentrated induction, and 3) the cells are 
recruited to the site of insult, then leading to an induction of p16
INK4a
.  There is strong 
evidence to show that p16
INK4a
 accumulates over time in both mice and humans with no 
translational repression, suggesting that our first hypothesis is possibly but unprecedented 
(Krishnamurthy et al., 2004; Liu et al., 2009).  Both our second and third hypotheses seem 
plausible especially with our data indicating a relationship between p16
INK4a
 transient 
expression and an inflammatory response.   
 As described in Chapter 3, we have recently determined that transient p16
INK4a
 
expression after UV wound exposure is ablated through disruption of the inflammatory 
process.  Moreover, macrophage depletion hindered p16
INK4a
 expression by half after wound 
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generation.  Additionally, peak induction of p16
INK4a
 induction correlates with macrophage 
infiltration during wound healing (Leibovich and Ross, 1975), suggesting p16
INK4a
 regulation 
is dependent on macrophage recruitment during an inflammatory response.  The experiments 
described in Chapter 3 will help solidify our hypothesis that p16
INK4a
 is found in the 
macrophages at the site of cellular insult, however, they will not determine if the 
macrophages have high levels of p16
INK4a
 before recruitment to injury or once macrophages 
reach the wound site then p16
INK4a
 expression occurs.  Potentially, single cell tracking can be 
employed to determine the p16
INK4a
 expression mechanism during macrophage recruitment.   
Additionally, further experimentation is necessary to determine if p16
INK4a
 is required for 
proper wound healing or rather simply a biomarker for the inflammatory response. 
 
4.5 Importance and Significance 
 This work has given the field a new, cost effective method for understanding how 
p16
INK4a
 expression correlates with chronic exposures in vivo.  These studies also further the 
relationship between p16
INK4a
 expression, senescence and aging (Chapter 2).  By better 
understanding the molecular mechanisms of aging, we can work towards better therapeutics 
of age-related diseases as well as lessen some of the effects after chronic exposures over a 
lifetime.  My work has also scratched the surface of the mechanism for transient induction of 
p16
INK4a
 expression in vivo.  The completed UV wound healing work along with my future 
experiments will demonstrate how p16
INK4a
 is transiently induced and will give us a platform 
to learn why p16
INK4a
 induction is necessary during a would repair response.  Eventually, this 
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work can help bridge the connection between p16
INK4a
 expression, chronic injury, and 
p16
INK4a
 -associated cancer and aging pathologies. 
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4.6 Figures 
 
Figure 4. 1 Design of of p16
TOM 
allele 
Schematic of the p16
TOM knockin targeting strategy. “Targeted allele” denotes the allele after 
Flp-recombinase-mediated excision of the neomycin selection cassette. 
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